Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A.E Bittar is active.

Publication


Featured researches published by A.E Bittar.


Transplantation Proceedings | 1999

Kidney graft failure due to noncompliance

T Michelon; V Dominguez; A Losekan; A Messias; R.M Bruno; A.E Bittar; E Keitel; A.F Santos; J.C Goldani; J Bianchinni; C.D Garcia; J Neumann; Valter Duro Garcia

RENAL transplantation is the treatment of choice for end-stage renal failure. However, the recipient needs a lifelong intake of immunosuppressive medication for the long-term success of the transplantation. There is a growing awareness of patient noncompliance with immunosuppression, which can result in rejection and graft loss. Recent data show rates of noncompliance ranging from less than 5% to more than 45%; it depends on time posttransplant and evaluation method. Noncompliance is one of the major causes of graft failure among renal transplant recipients. The objective of this study was to evaluate the present rate of graft loss due to noncompliance among our patients and to identify factors associated with noncompliance.


Jornal Brasileiro De Nefrologia | 2014

Histopathological analysis of pre-implantation donor kidney biopsies: association with graft survival and function in one year post-transplantation

Karla Lais Pêgas; Karine Michel; Valter Duro Garcia; J.C Goldani; A.E Bittar; Daniela Seelig; Eduardo Cambruzzi; Elizete Keitel

INTRODUCTION Pre-implantation kidney biopsy is a decision-making tool when considering the use of grafts from deceased donors with expanded criteria, implanting one or two kidneys and comparing this to post-transplantation biopsies. The role of histopathological alterations in kidney compartments as a prognostic factor in graft survival and function has had conflicting results. OBJECTIVE This study evaluated the prevalence of chronic alterations in pre-implant biopsies of kidney grafts and the association of findings with graft function and survival in one year post-transplant. METHODS 110 biopsies were analyzed between 2006 and 2009 at Santa Casa de Porto Alegre, including live donors, ideal deceased donors and those with expanded criteria. The score was computed according to criteria suggested by Remuzzi. The glomerular filtration rate (GFR) was calculated using the abbreviated MDRD formula. RESULTS No statistical difference was found in the survival of donors stratified according to Remuzzi criteria. The GFR was significantly associated with the total scores in the groups with mild and moderate alterations, and in the kidney compartments alone, by univariate analysis. The multivariate model found an association with the presence of arteriosclerosis, glomerulosclerosis, acute rejection and delayed graft function. CONCLUSION Pre-transplant chronic kidney alterations did not influence the post-transplantation one-year graft survival, but arteriosclerosis and glomerulosclerosis is predictive of a worse GFR. Delayed graft function and acute rejection are independent prognostic factors.


Transplant International | 2003

Rituximab in association with rapamycin for post‐transplant lymphoproliferative disease treatment

Valter Duro Garcia; Jose Luz Bonamigo Filho; J Neumann; Laura Fogliatto; Anna Maria Geiger; C.D Garcia; Vivianne Barros; E Keitel; A.E Bittar; Auri Ferrera Des Santos; Sérgio Roithmann


Transplantation Proceedings | 2004

Pregnancy outcome after renal transplantation

E Keitel; R.M Bruno; M Duarte; A.F Santos; A.E Bittar; P.D Bianco; J.C Goldani; Valter Duro Garcia


Transplantation Proceedings | 2002

Noncompliance as a cause of renal graft loss

T Michelon; F Piovesan; R Pozza; C Castilho; A.E Bittar; E Keitel; A.F Santos; J.C Goldani; C.D Garcia; J Neumann; Valter Duro Garcia


Transplantation Proceedings | 2001

Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study ☆

A.F Santos; E Keitel; A.E Bittar; J Neumann; F.D Fuchs; J.C Goldani; N.A Fonseca; V.C Prates; D Zaffan; C Voegeli; L Kroth; G Steffenello; D Saitovitch; Valter Duro Garcia


Transplantation Proceedings | 2005

Antigenemia for cytomegalovirus in renal transplantation : Choosing a cutoff for the diagnosis criteria in cytomegalovirus disease

R. Schröeder; T Michelon; I. Fagundes; A. Bortolotto; E Lammerhirt; J. Oliveira; A.F Santos; A.E Bittar; E Keitel; Valter Duro Garcia; J Neumann; David Saitovitch


Transplantation Proceedings | 2002

Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.

Valter Duro Garcia; J.S Bonamigo-Filho; J Neumann; Laura Fogliatto; A.M Gaiger; C.D Garcia; V.R Barros; E Keitel; A.E Bittar; A.F Santos; Sérgio Roithmann


Transplantation Proceedings | 2004

Cytomegalovirus Disease Latent and Active Infection Rates During the First Trimester After Kidney Transplantation

R Schroeder; T Michelon; I. Fagundes; A. Bortolotto; E Lammerhirt; J Oliveira; A.F Santos; A.E Bittar; E Keitel; Valter Duro Garcia; J Neumann; D Saitovitch


Transplantation Proceedings | 1997

Patient noncompliance as a major cause of kidney graft failure

Valter Duro Garcia; A.E Bittar; E Keitel; J.C Goldani; M. Minozzo; M. Pontremoli; C.D Garcia; J Neumann

Collaboration


Dive into the A.E Bittar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Bortolotto

Pontifícia Universidade Católica do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Auri Ferreira dos Santos

Pontifícia Universidade Católica do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge